argenx SE (ARGNF)
OTCMKTS · Delayed Price · Currency is USD
870.00
-2.27 (-0.26%)
At close: Nov 11, 2025
argenx SE Employees
argenx SE had 1,599 employees as of December 31, 2024. The number of employees increased by 451 or 39.29% compared to the previous year.
Employees
1,599
Change (1Y)
451
Growth (1Y)
39.29%
Revenue / Employee
$2,303,490
Profits / Employee
$958,878
Market Cap
53.56B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 1,599 | 451 | 39.29% |
| Dec 31, 2023 | 1,148 | 305 | 36.18% |
| Dec 31, 2022 | 843 | 193 | 29.69% |
| Dec 31, 2021 | 650 | 314 | 93.45% |
| Dec 31, 2020 | 336 | 150 | 80.55% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| American Oncology Network | 1,914 |
| Jushi Holdings | 1,234 |
| Glass House Brands | 374 |
| Silence Therapeutics | 116 |
| Elite Pharmaceuticals | 68 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| OpGen | 1 |
argenx SE News
- 8 hours ago - argenx: TED Phase 3 Failure, Vyvgart Growth, And Why I'm Still A Hold - Seeking Alpha
- 13 hours ago - RBC Capital Raises Price Target for ARGX to $925, Maintains 'Outperform' | ARGX Stock News - GuruFocus
- 1 day ago - Wells Fargo Lowers Price Target for ARGX but Maintains Overweight Rating | ARGX Stock News - GuruFocus
- 1 day ago - Touchstone Sands Capital International Growth Equity Fund Q3 2025 Portfolio Update - Seeking Alpha
- 2 days ago - Argenx (ARGX) Ends Study of Efgartigimod for Thyroid Eye Disease - GuruFocus
- 2 days ago - Argenx Halts Phase 3 Thyroid Eye Disease Trial, Peers Like Viridian Therapeutics To Benefit - Benzinga
- 2 days ago - Argenx Halts Phase 3 Thyroid Eye Disease Trial, Peers Like Viridian Therapeutics To Benefit - Benzinga
- 2 days ago - Argenx Flops, As Viridian Celebrates, On Surprise Setback For Vyvgart Powerhouse - Investor's Business Daily